Mixed Topics
Feature
Building an AI Army of Digital Twins to Fight Cancer
What if there were a way to test — quickly and accurately — all the potential paths forward?
From the Journals
Smokeless Tobacco, Areca Nut Chewing Behind 1 in 3 Oral Cancers: IARC Report
‘Our estimates highlight the burden these products pose on health care and the importance of prevention strategies to reduce consumption of...
Latest News
Study Finds No Significant Effect of Low-Dose Oral Minoxidil on BP
Hypotensive symptoms were reported in 5% patients, with no significant hypotensive episodes.
From the Journals
Many Patients With Cancer Visit EDs Before Diagnosis
Factors associated with an increased likelihood of an ED visit ahead of diagnosis included having certain cancers, living in rural areas, and...
From the Journals
Plasma Omega-6 and Omega-3 Fatty Acids Inversely Associated With Cancer
The findings support possible small net protective roles of omega-3 and omega-6 PUFAs in the development of new cancer incidence, the researchers...
Commentary
On Second Thought: Aspirin for Primary Prevention — What We Really Know
Recommendations vis-à-vis aspirin have evolved at a dizzying pace.
Latest News
Cosmetic Dermatology Product Recalls Still Common, Analysis Finds
During the study period, 334 voluntary and manufacturer-initiated recalls of cosmetic products were reported, affecting 77,135,700 units.
Feature
Should the Body Roundness Index Replace BMI?
Several studies have suggested that BRI could be a valuable tool for assessing health risks.
Commentary
Cardiovascular Disease 2050: No, GLP-1s Won’t Save the Day
Harvard Medical School professor tells “where we will be in 2050” if prior trends remain the same.
Latest News
ICD-10-CM Codes for CCCA, FFA Now Available
“This development represents a positive step toward improving care for individuals affected by these challenging conditions,” said Amy McMichael,...
From the Journals
Industry Payments to Peer Reviewers Scrutinized at Four Major Medical Journals
Major medical journals relied on peer reviewers who received more than $64 million in non-research payments between 2020 and 2022.